DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Calabresi PA, Kieseier BC, Arnold DL et al.
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study.
Lancet Neurol 2014;
13: 657-665
We do not assume any responsibility for the contents of the web pages of other providers.